Oprelvekin en es it fr

Oprelvekin Brand names, Oprelvekin Analogs

Oprelvekin Brand Names Mixture

  • No information avaliable

Oprelvekin Chemical_Formula

C854H1411N253O235S2

Oprelvekin RX_link

http://www.rxlist.com/cgi/generic3/oprelvek.htm

Oprelvekin fda sheet

Oprelvekin msds (material safety sheet)

Oprelvekin Synthesis Reference

No information avaliable

Oprelvekin Molecular Weight

19047.2

Oprelvekin Melting Point

No information avaliable

Oprelvekin H2O Solubility

No information avaliable

Oprelvekin State

Liquid

Oprelvekin LogP

-0.070

Oprelvekin Dosage Forms

Powder for solution; Solution (subcutaneous injection)

Oprelvekin Indication

Increases reduced platelet levels due to chemotherapy

Oprelvekin Pharmacology

Oprelvekin is indicated for the prevention of severe thrombocytopenia and the reduction of the need for platelet transfusions following myelosuppressive chemotherapy in adult patients with nonmyeloid malignancies who are at high risk of severe thrombocytopenia. The primary hematopoietic activity of Oprelvekin is stimulation of megakaryocytopoiesis and thrombopoiesis. Oprelvekin has shown potent thrombopoietic activity in individuals with compromised hematopoiesis

Oprelvekin Absorption

No information avaliable

Oprelvekin side effects and Toxicity

No information avaliable

Oprelvekin Patient Information

No information avaliable

Oprelvekin Organisms Affected

Humans and other mammals